Sleep Cycle: Sleep apnea launches in Europe first, US pathway paused - Redeye

Redeye comments briefly on Sleep Cycle's decision to CE mark its sleep apnea risk detection solution as a Class I medical device in Europe, enabling an earlier EU/UK launch, while deferring further investment in the US FDA pathway until commercial evidence from Europe is in hand.

Länk till analysen i sin helhet: https://www.redeye.se/research/1185167/sleep-cycle-sleep-apnea-launches-in-europe-first-us-pathway-paused?utm_source=finwire&utm_medium=RSS